Mechanistically, NAD+ deficiency in TILs drives mitochondrial dysfunction and reduces ATP production, whereas supplementation with nicotinamide (NAM), the substrate of NAMPT, reverses these effects to promote a strong anti-tumor immune response in vivo[103]. The gene discussed is NAMPT; the disease is neoplasm.